Cancer Center and Mile Square Pursuing Leading-edge Diagnostics and Therapeutics
article part 1 Heading link
Five members of the University of Illinois Cancer Center have received more than $2.2 million in NIH grants for research into novel approaches to treating cancer. With the funding, Dr. Tohru Yamada (College of Medicine), Dr. Konstantinos Chronis (College of Medicine), Dr. Toru Nakamura (College of Medicine), Dr. Susan Ross (College of Medicine), and Dr. Zongmin Zhao (College of Pharmacy) will investigate probiotic bacteria-assisted treatment, reprogramming hematopoietic stem cells, regulation of telomere maintenance, viral replication of retroviruses and nanoparticle therapeutics.
Article part 2 Heading link
Mile Square Health Center, in partnership with the Cancer Center, will be the first site in the state to participate in a national study of a screening to detect a cancer signal shared by over 50 types of cancer. Currently, many of these cancers, including pancreatic and blood cancers, may go undetected because there are no recommended screening tests for them. The patient populations served by the Cancer Center, who often have disproportionately high rates of cancer, are uniquely diverse and their participation will ensure equitable representation in the study data.